RedHill Biopharma Ltd. (RDHL) Form 6-K — Jun 22, 2026
RedHill Biopharma Ltd. entered into a Securities Purchase Agreement with an accredited investor for a private placement issuing 8,571,429 American Depositary Shares and accompanying warrants. The offering price was set at $0.70 per ADS and warrant, with gross proceeds expected to be approximately $6 million. The transaction included Series A-1 and A-2 warrants to purchase up to 8,571,429 ADSs each, exercisable immediately with terms of five years and 18 months respectively.
Key figures
- Gross Proceeds
- 6,000,000
- Offering Price
- 0.70
- Shares Offered
- 8,571,429
- Placement agent fee
- 7.5%
- Placement agent warrants
- 514,286
- Series a1 warrant strike
- 0.86
- Series a2 warrant strike
- 0.70
- Series a1 warrants shares
- 8,571,429
- Series a2 warrants shares
- 8,571,429
- Potential warrant proceeds
- 13,400,000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.